DNTH Dianthus Therapeutics Inc Total Asset Value of Company
Dianthus Therapeutics (DNTH) is managed by a team of specialized professionals with deep experience in drug discovery and a transparent leadership structure. The business focuses on identifying treatments for autoimmune pathologies, while a lack of sales leaves the company dependent on external financing. Total assets amount to 769.62. The available price action reflects high volatility driven by R&D expenditures and clinical trial risks.
Analytical breakdowns and data insights for company Dianthus Pharma (DNTH)
- stock price and consensus target price:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Dianthus Therapeutics|DNTH - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Dianthus Corp|DNTH - Company Aggregate Debts|Debts to Book Capitalization Dianthus Corp|DNTH - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Dianthus Therapeutics|Interim Coverage Ratio dianthustx.com
- net income and valuation multiples indicators:
Fundamental valuation:Dianthus Therapeutics
When constructing a defensive portfolio, analyzing the total resources—which this indicator determines inversely via ROA by summing liabilities and equity to assess the actual scale of the business—is critically important. In the case of Dianthus Therapeutics (DNTH), the growth trend of all company resources reflects investments in creating a technological barrier through the development of innovative monoclonal antibodies, confirming the expansion of the material base for combating rare diseases.
Key competitors
argenx.com - Aggregate Asset Value|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|ANAB (AnaptysBio Inc.) - Total Business Assets|ATXS: Company Total Assets|ENGN - Company Total Asset Base|RAPT (RAPT Therapeutics) - Company Total Assets|Company Total Assets Aerovate|Aggregate Company Assets Aclaris (ACRS)|Kyverna Therapeutics, Inc - Total Business Assets|Tiziana Life Sciences - Cumulative Company Assets|Aggregate Business Assets CABA (cabalettabio.com)|Ventyx Biosciences, Inc. - Company Total Assets|Aggregate Asset Value THTX (Theratechnologies, Inc.)|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|Eledon Pharmaceuticals, Inc (ELDN) - Company Total Assets|Aggregate Company Assets Agenus|climbbio.com (CLYM) - Company Total Asset Base|Cumulative Company Assets ZURA (Zura Bio)|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Adagene Inc. - Cumulative Company Assets|Aggregate Business Assets IMA (ImageneBio)|Shattuck Therapeutics - Company Total Assets|Aggregate Asset Value EQ (Equillium, Inc.)|CNTB: Company Total Assets|Company Assets Immunic (IMUX)|Aggregate Company Assets Atara Biotherapeutics, Inc.|IFRX: Aggregate Asset Value|Company Total Assets XFOR|Company Total Assets adicetbio.com (ACET)|Aggregate Company Assets Celularity CELU|INMB (INmune Bio Inc) - Total Asset Value of Company|Barinthus Bio - Company Total Assets|Company Assets Kezar Life Sciences Inc|SABS (SAB Biotherapeutics) - Cumulative Company Assets|akaritx.com (AKTX) - Company Total Assets|Cumulative Company Assets ENLV|QTTB (Q32 Bio Corp) - Aggregate Business Assets|Company Total Assets GOVX|Company Total Asset Base Edesa Biotech Corp|Company Total Assets IBIO (iBio, Inc.)|CARM - Cumulative Company Assets|XTLB - Aggregate Company Assets|Company Total Asset Base Bolt Biotherapeutics BOLT|HCWB: Company Total Assets|Total Business Assets APVO|Aggregate Company Assets AIM ImmunoTech Inc.|Total Business Assets ADTX (Aditxt Corp)|Cumulative Company Assets GRI (GRI Bio)|Aggregate Business Assets XRTX|Company Total Assets HIND (ReShape Lifesciences)|Aggregate Asset Value REVB|INDP - Aggregate Company Assets|Total Asset Value of Company SCNI|CALI: Company Total Assets|Affimed N.V. - Aggregate Asset Value|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|Third Harmonic Bio, Inc - Company Total Assets